Loading
No description yet: the sentence for this tag has not been written. 2 records carry it: 2 protocols.
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
EGFR inhibitor rash: pre-emptive skin care, antibiotics and dose changes Drugs that block EGFR, such as cetuximab, panitumumab, amivantamab and EGFR tablets for lung cancer, very often cause an acne-like rash. Starting skin care on day one makes a bad rash much less likely: doxycycline or minocycline for the first weeks, moisturiser, sunscreen, and sometimes a mild steroid cream. Tell your team early if it spreads or hurts: a pause or lower dose may help. | Colorectal cancer, EGFR-mutated non-small-cell lung cancer | none | protocol, egfr-inhibitor, supportive-care | ||
Hand-foot syndrome and hand-foot skin reaction: prevention, skin care and dose changes Capecitabine, liposomal doxorubicin and tablets such as sorafenib and regorafenib can make the palms and soles red, sore, peeling or blistered. From the start, avoid rubbing, heat and long soaks, wear well-fitting shoes and moisturise daily; with sorafenib, a 10 per cent urea cream from day one helps. If hands or feet become painful or limit what you do, stop capecitabine and call your team. | none | none | protocol, hand-foot-syndrome, supportive-care |